Home › Psoriatic Arthritis › New York
Psoriatic Arthritis clinical trials in New York
8 studies for Psoriatic Arthritis are looking for participants at sites in New York.
Cities in New York
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- NYU Langone Hospital - Long Island, Mineola
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- and 1 more
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT03816345A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
- NYU Langone Health | Joseph S. and Diane H. Steinberg Ambulatory Care Center - Rheumatology Department, Brooklyn
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT06671483Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015)
- Joseph S. and Diane H. Steinberg Ambulatory Care Center ( Site 5106), Brooklyn
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Sep 14, 2026 · NCT07486960Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response
- Clinical Site, Brooklyn
- Clinical Site, Rochester
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 11, 2026 · NCT06641089A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
- Columbia University Medical Center /ID# 262587, New York
- Boston Childrens Health Physicians /ID# 258061, Valhalla
RecruitingPhase 3
Ages 5 to 17 · All sexes · Updated Sep 1, 2026 · NCT06100744Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
- Albany Medical College, Albany
- Cohen Children's Medical Center of New York, Lake Success
- Hospital for Special Surgery, New York
- and 3 more
RecruitingObservational study
Up to age 21 · All sexes · Updated Aug 27, 2026 · NCT02418442Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
- NYU Langone Health, New York
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 9, 2026 · NCT07138898Guselkumab vs Golimumab in PsA TNF Inadequate Responder Patients
- New York University, New York
RecruitingPhase 3
Ages 18 to 80 · All sexes · Updated Oct 9, 2025 · NCT05669833From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.